Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

about

Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women.Comorbidities in rheumatic arthritis

P2860

Q47577858-A70850B9-FDDF-418B-8052-57A14407C3ED Q58779794-CF18C75C-758C-4808-92B5-D698E96B00CB

P2860

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

Item

http://www.wikidata.org/entity/Q39309064

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

@en

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

@nl

type

Item

label

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

@en

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

@nl

prefLabel

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

@en

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

@nl

P1476

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

@en

P2093

Eric L Matteson

http://www.w3.org/2001/XMLSchema#string

Katelynn M Wilton

http://www.w3.org/2001/XMLSchema#string

P2860

Biologics, cardiovascular effects and cancer

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Leflunomide reduces proliferation and induces apoptosis in neuroblastoma cells in vitro and in vivo

Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data.

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials.

Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting.

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.

P2888

s40744-017-0064-4

P304

333-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40744-017-0064-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28508282

http://www.w3.org/2001/XMLSchema#string

P932

5696277

http://www.w3.org/2001/XMLSchema#string

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

about

P2860

P2860

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932